Results 101 to 110 of about 184,119 (211)

Cancer vaccine overcomes immune evasion of nasopharyngeal carcinoma by restoring MHC-I through transcriptional regulation of NLRC5. [PDF]

J Transl Med
Gan CP, Kok SY, Lee BKB, Zulaziz N, Cheong SC, Savelyeva N, Lim KP.   +6 more
europepmc   +1 more source

Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine. [PDF]

Cancer Immunol Immunother
Kofoed SV, Barrio-Calvo M, Pavlidis MA, Kleine-Kohlbrecher D, Lausen M, Lunabjerg-Vestergaard C, Viborg N, Garde C, Rønø B, Friis S.   +9 more
europepmc   +1 more source

A Programmable Nanovaccine Platform Based on M13 Bacteriophage for Personalized Cancer Vaccine and Therapy. [PDF]

Adv Mater
Huang S, He Y, Madow A, Peng H, Griffin M, Qi J, Huang M, Amoroso H, Abrashoff R, Heldman N, Belcher AM.   +10 more
europepmc   +1 more source

Data Sheet 4_Development of a multi-neoepitope vaccine targeting non-small cell lung cancer through reverse vaccinology and bioinformatics approaches.xlsx

Elahe Asadollahi (21373565), Alireza Zomorodipour (8910398), Zahra-Soheila Soheili (4268341), Babak Jahangiri (17636354), Majid Sadeghizadeh (464855)   +4 more
openalex   +1 more source

Harnessing adjuvant-induced epigenetic modulation for enhanced immunity in vaccines and cancer therapy [PDF]

Yasmine Megdiche, Rosângela Salerno-Gonçalves   +1 more
openalex   +1 more source

Using Bacterial Vectors for Probable Vaccines: From Molecular Mechanism to Cancer Therapy

, 2020
Parnia Jabbari
openalex   +2 more sources

Targeting breast cancer vaccines to dendritic cells: improved immunological responses with less protein? [PDF]

, 2012
Anne Armstrong, David E. Gilham
openalex   +1 more source

Shared neoantigens' atlas for off-the-shelf cancer vaccine development. [PDF]

J Transl Med
Mauriello A, Cavalluzzo B, Ragone C, Tagliamonte M, Buonaguro L.   +4 more
europepmc   +1 more source

Development of the rationale of a personalized cancer vaccine based on the in situ vaccine effect of radiotherapy: a mechanistic study of the POLARSTAR trial. [PDF]

Cancer Immunol Immunother
Pang K, Sun P, Liu X, Yang D, Zhao P, Huang Y, Cao S, Gao Y, Chen G, Yu H, Duan L, Yang Y, Zhang Z.   +12 more
europepmc   +1 more source

Adults with blood cancers respond to booster, not initial dose of COVID-19 vaccine.

, 2022

openalex   +1 more source